-
The total investment is 3.05 billion yuan! The foundation laying and commencement of TUL (Gaolan Port) project
On November 22, 2023, the groundbreaking ceremony for the United Laboratories (Gaolan Port) project was held in Nanshui Town, Jinwan District, Zhuhai City. More than 200 people, including leaders of the Zhuhai Municipal Government, senior executives and emplo...
Date： 2024-03-25 Browse：106
-
TUL won the "ESG Special Commendation Award"
On November 9, 2023, the TVB Environmental, Social and Governance Awards 2023 ceremony was held in Hong Kong, and The United Laboratories International Holdings Limited (3933. HK) was awarded the ESG Special Commendation Award.
Date： 2024-03-25 Browse：86
-
Chairman of the Board of Directors of TUL, Tsoi Hoi Shan, visited and exchanged ideas with Wens Group in Guangdong
On October 31, 2023, Tsoi Hoi Shan, Chairman of the Board of Directors of TUL, and Liu Hongchi, General Manager of The United Animal Healthcare (Inner Mongolia) Co., Ltd., visited and inspected the headquarters of Wens Group in Guangdong.
Date： 2024-03-25 Browse：98
-
Tsoi Hoi Shan is honored to serve as Honorary President of Jinwan Hong Kong & Macau Chamber of Commerce
On October 28, 2023, the inaugural ceremony of the first Executive Council of the Jinwan Hong Kong & Macau Chamber of Commerce was held in Hong Kong, and the Chairman of the Board of Directors of the United Laboratories, Tsoi Hoi Shan, was honored as the Hono...
Date： 2024-03-25 Browse：91
- TUL Degu and Liraglutide insulin compound preparation obtained clinical approval. Date： 2023-04-26 Browse：0
-
TUL Amoxicillin Capsules (specification: 0.5g) passed the consistency evaluation of generic drugs
Recently, TUL obtained the Notice of Approval of Supplementary Drug Application for Amoxicillin Capsules (specification: 0.5g) approved and issued by NMPA, which approved this product to pass the quality and efficacy consistency evaluation of generic drugs.
Date： 2023-04-26 Browse：656
- 2022 Annual Results Announcement Date： 2023-04-20 Browse：0
-
Insulin glargine approved for marketing, United Lab overcomes another challenge in diabetes drug
Date： 2017-12-08 Browse：4080
After a rigorous site check and evaluation of clinical test data, insulin glargine, the human insulin analog developed independently by United Lab using DNA gene recombination technology, is finally granted with the approval document today and will go to mark...